Nicox Ophthalmics, Inc.

This study tested a new eye drop called NCX 470 in 696 people with open-angle glaucoma or high eye pressure. Participants used the drop once daily for up to 12 months, and researchers measured how well it lowered eye pressure compared to a standard treatment, latanoprost. The goa…

This study looked at how NCX 470 eye drops change the flow of fluid inside the eye. Researchers measured fluid production, drainage, and pressure in 18 healthy volunteers or people with high eye pressure. The goal was to understand how the drops work to lower pressure, which coul…